Declaration of shares and voting rights of Valneva SE March 2026
VALNEVA Declaration of shares and voting rights March 31, 2026__________________________________________________________________________________________ Company name:…
Valneva to Participate in Multiple Events at the 26th World Vaccine Congress in Washington DC
Lyon (France), March 26, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris:…
VALNEVA Declaration of shares and voting rights: January 31, 2026
VALNEVA Declaration of shares and voting rights January 31, 2026__________________________________________________________________________________________ Company name:…
Valneva Provides Update on Chikungunya Vaccine IXCHIQ
Company voluntarily withdraws IXCHIQ BLA and IND in the U.S. Continuing review of…
Valneva and Serum Institute of India Announce Discontinuation of Chikungunya Vaccine License Agreement
Saint-Herblain (France), Pune, (India), December 31, 2025 – Valneva SE (“Valneva” or…
Valneva Announces Lifting of European Medicines Agencys Temporary Restriction on Use of Chikungunya Vaccine IXCHIQ in Elderly
Saint Herblain (France), July, 11 2025 – Valneva SE (Nasdaq: VALN; Euronext…
